CD4 and breast cancer: For example, HSPA8 + Treg-C1 were identified as unfavorable for BC survival, whereas RSF1 + Macro-C1, NAP1L1 + Macro-C2, DEK + Macro-C3, ATRX + Macro-C4, NoneHistone_Macro-C10, RSF1 + B-C1, HSPA8 + B-C2, DEK + B-C3, ATRX + B-C4, ATRX + CD4 + T-C1, BAZ1A + CD4 + T-C3 and NCL + CD8 + T-C3 were associated with a favorable prognosis in BC (Fig. 5C).